Furthermore, WISP1 appears to act as a regulator of extracellular matrix remodeling in breast cancer, broadly enhancing the expression of matrix metalloproteinases, including MMP1, MMP2, MMP9, and MT1-MMP, and shifting the MMP/TIMP balance toward a proteolytic phenotype [37,38]. This evidence concerns the gene CCN4 and breast cancer.